ACNE TREATMENT MARKET Research Report Information by Therapeutic Type (Oral [Antibiotics, Contraceptives, Retinoids, Hormonal], Topical [Antibiotics, Retinoids, Benzoyl Peroxide, Salicylic Acid, Azelaic Acid, and Others], Systemic [Antibiotics and Intralesional Steroid Injections], by Prescription Type (Prescription-based and Over-the-counter (Non-prescription-based) by Acne Severity (Low, Moderate, and High), by Gender (Male and Female), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online) and by Region (North Ameri

Global Acne Treatment Market Overview

Acne Treatment Market size was valued at USD 10.00 billion in 2024. The Acne Treatment Market industry is projected to grow from USD 10.40 billion in 2025 to USD 15.98 billion by 2035, exhibiting a compound annual growth rate (CAGR) of 5.34% during the forecast period (2025 - 2035).

The factors that are driving the growth of the global market are the growing prevalence of acne across the globe and topical treatments gaining popularity.

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Acne Treatment Market Trends

  Growing prevalence of acne across the globe

The aesthetics industry across the globe is experiencing a significant surge in demand, propelled by a growing interest in advanced procedures designed to enhance skin health and appearance. The growing prevalence of acne worldwide is a key driver of the Acne Treatment Market's expansion. Acne, affecting individuals of all ages but especially teenagers and young adults, is becoming increasingly common due to factors such as hormonal changes, stress, poor diet, pollution, and genetics. For instance, in February 2024, the Journal of the American Academy of Dermatology (JAAD) published a study that provides a comprehensive view of acne’s prevalence worldwide. It uncovers significant variations in acne rates across age groups, genders, geographic regions, and its impact on quality of life and stigmatization. The study found that acne affects 20.5% of the global population, with the highest prevalence in adolescents and young adults (16-24 years old) at 28.3%. Acne remains notably high among adults aged 25 to 39 years, at 19.3%. Women are more affected by acne than men, with a prevalence of 23.6% in women compared to 17.5% in men. Significant differences were observed across geographic regions: Latin America (23.9%), East Asia (20.2%), Africa (18.5%), the Middle East (16.1%), Europe (9.7%), and Australia (10.8%).

Topical treatments are gaining significant popularity in the Acne Treatment Market due to their convenience, effectiveness, and accessibility. Products such as benzoyl peroxide, salicylic acid, azelaic acid, and retinoids like adapalene and tretinoin have become staple solutions for managing acne, especially among individuals with mild to moderate severity. These treatments are highly sought after because they can be easily incorporated into daily skincare routines without the need for professional intervention. For instance, in March 2021, Galderma's released a "Me Being Me" digital campaign for Aklief is significantly boosting the growth of the topical Acne Treatment Market by raising awareness and encouraging young acne sufferers to seek treatment. The campaign addresses the emotional challenges faced by those with acne, especially in the context of increased video calls during the pandemic. By sharing authentic stories and offering inspiration, the campaign empowers young people to embrace their skin and consult a dermatologist for solutions like Aklief. Through targeted social media channels such as TikTok, Instagram, Snapchat, and influencer partnerships, the campaign effectively educates and motivates the target audience, driving demand for topical acne treatments and contributing to market growth.

In conclusion, the global surge in the aesthetics industry is driven by increasing acne prevalence and a growing demand for effective, accessible treatments. Topical solutions like benzoyl peroxide and retinoids are becoming increasingly popular, supported by campaigns like Galderma's "Me Being Me," which raise awareness and encourage young people to seek treatment, further fueling market growth.

Acne Treatment Market Segment Insights

Acne Treatment Market Therapeutic Type Insights

Based on therapeutic area, the Acne Treatment Market has been segmented into oral, tropical, and systemic. The oral segment held the largest market share in 2024, and the systemic segment is the fastest-growing segment during the forecast period (2025 -2035).

Oral treatments represent a significant segment of the Acne Treatment Market, particularly for individuals with moderate to severe acne or cases resistant to topical therapies. Key oral medications include antibiotics like tetracycline and doxycycline, which target acne-causing bacteria and reduce inflammation. Hormonal treatments, such as oral contraceptives containing estrogen and progestin, are widely used for hormonal acne, regulating hormone levels and controlling sebum production. Spironolactone, an anti-androgen medication, is another effective option, particularly for women with acne linked to hormonal imbalances. Moreover, in 2023, the antibiotics segment dominated the market. Antibiotics are becoming increasingly popular for acne treatment due to their effectiveness in managing exudate. Thus, antibiotics dominate the global market and are expected to hold the largest share during the forecast period. Furthermore, various research have shown that antibiotics are useful for acne treatment. For example, in March 2023, the Yale School of Medicine published a study demonstrating the efficiency of various antibiotics and determining which types of these medications are best suited for acne treatment.

FIGURE 2: Acne Treatment Market, BY THERAPEUTIC TYPE, 2024 & 2035 (USD BILLION)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Acne Treatment Market Prescription Type Insights

Based on prescription type, the Acne Treatment Market has been segmented into prescription based, and over the counter. The prescription-based segment held the largest market share in 2024, and the over-the-counter segment is the fastest-growing segment during the forecast period (2025 -2035).

Prescription-based acne treatments include oral medications like antibiotics (e.g., doxycycline and minocycline) that help control bacterial growth and inflammation. For more severe cases, isotretinoin (Accutane), an oral retinoid, is often prescribed due to its ability to significantly reduce sebum production and prevent clogged pores. Prescription-strength topical treatments, such as tretinoin and clindamycin, are also commonly used to treat acne by promoting skin cell turnover and targeting bacteria directly. Hormonal therapies like oral contraceptives and spironolactone are prescribed for acne related to hormonal imbalances, particularly in women. While these treatments are highly effective, they can be associated with side effects such as dryness, gastrointestinal issues, or liver toxicity, requiring careful monitoring.

Acne Treatment Market Acne Severity Insights

Based on acne severity, the Acne Treatment Market has been segmented into low, moderate, high. The low segment held the largest market share in 2024 and is the fastest-growing segment during the forecast period (2025 -2035).

Low acne severity refers to mild cases, typically involving occasional breakouts such as a few pimples, blackheads, or whiteheads. These cases usually do not involve significant inflammation or cystic lesions and can be effectively managed with over the counter (OTC) treatments. Common OTC solutions include products containing benzoyl peroxide, salicylic acid, or adapalene, which help control oil production, reduce bacteria, and prevent clogged pores.

Acne Treatment Market Gender Insights

Based on gender, the Acne Treatment Market has been segmented male and female. The female segment held the largest market share in 2024 and is the fastest-growing segment during the forecast period (2025 -2035).

The male Acne Treatment Market is experiencing significant growth, driven by increasing awareness of acne's impact on men’s self-esteem and skin health. Acne, which is common during adolescence and often persists into adulthood, tends to be more severe in men due to higher sebum production and thicker skin. As a result, there is rising demand for targeted treatments tailored to male skin. Popular solutions include OTC products containing benzoyl peroxide, salicylic acid, and adapalene, as well as oral medications like antibiotics and isotretinoin for more severe cases. Additionally, advanced therapies such as laser treatments and chemical peels are gaining traction for their ability to treat acne and minimize scarring.

Acne Treatment Market Distribution Channel Insights

Based on distribution channel, the Acne Treatment Market has been segmented into hospital pharmacies, retail pharmacies and online. The hospital pharmacies segment held the largest market share in 2024, and the online segment is the fastest-growing segment during the forecast period (2025 -2035).

Hospital pharmacies are a critical component of the Acne Treatment Market, particularly for patients with moderate to severe cases that require prescription-based solutions and specialized care. They play a pivotal role in dispensing prescription medications such as isotretinoin, oral antibiotics, and stronger topical retinoids, which are essential for managing severe acne. Additionally, hospital pharmacies collaborate with dermatologists to offer personalized treatment plans tailored to individual patients’ needs, enhancing treatment efficacy. With a focus on patient education and medication adherence, hospital pharmacies help ensure optimal treatment outcomes while minimizing risks. This segment presents significant growth opportunities for companies that provide specialized, prescription-only acne treatments and advanced therapies, as the demand for comprehensive, medically supervised acne management continues to rise.

Acne Treatment Market Regional Insights

Based on the region, the Acne Treatment Market has been segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America accounted for the largest market share in 2023 and is anticipated to reach during the forecast period. However, Asia-Pacific is projected to grow at the highest CAGR during the forecast period.

The Acne Treatment Market in North America is experiencing significant growth, driven by a combination of factors. The rising prevalence of acne, particularly among teenagers and adults, is a major contributor to the increased demand for treatments. For instance, Acne is the most common skin problem in the United States, impacting an estimated 50 million people each year. Acne typically occurs during puberty and affects many adolescents and young adults. Approximately 85% of people between the ages of 12 and 24 have at least minor acne. As consumers become more aware of skincare and the various acne solutions available, fueled by social media and beauty influencers, they are more inclined to seek effective treatments.

Further, the major countries studied are: The US, Canada, Brazil, Germany, France, the UK, Italy, Spain, China, India, Japan, South Korea, and Australia.

FIGURE 3: Acne Treatment Market, BY REGION, 2024 & 2035 (USD BILLION)

 Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

The Acne Treatment Market in Europe is growing due to several key drivers. Firstly, the increasing prevalence of acne, especially among adolescents and adults, is a major factor. Acne is not just a teenage issue but also affects adults, leading to a higher demand for treatment. The growing awareness of skincare and acne management, influenced by social media, influencers, and dermatologists, has also led to more people seeking effective acne solutions. The research-based pharmaceutical sector has the potential to significantly contribute to the expansion of the acne medicine market in Europe and ensure its future competitiveness in the global economy. Formel Skin, a Berlin-based company that pioneered dermatology telehealth, has announced the completion of a US$ 32.35 (30) million series financing round in January 2022. Singular and Heal Capital led the investment round, with support from Cherry Ventures, Heartcore Capital, and Vorwerk Ventures. With this money, the company intends to continue developing and expanding its remote skincare platform.

The Acne Treatment Market in the Asia Pacific (APAC) region is being driven by several key factors. The large and growing population of adolescents and young adults, particularly in countries like India, China, and Japan, is a major contributor, as these groups are more prone to acne. Additionally, increased awareness of skincare and beauty trends, largely fueled by social media and influencers, is driving demand for effective acne treatments. Rapid urbanization and lifestyle changes, including exposure to pollution, dietary shifts, and higher stress levels, have also contributed to a rise in acne cases. Economic growth and higher disposable incomes in many APAC countries allow consumers to invest in both over the counter and prescription treatments. Moreover, China Acne Treatment Market held the largest market share in 2024, and Australia Acne Treatment Market is the fastest growing market in the Asia-Pacific region.

Acne Treatment Market Key Market Players & Competitive Insights

The Acne Treatment Market is distinguished by the presence of numerous regional and local players catering to the Acne Treatment Market. Furthermore, the growing prevalence of acne across the globe, topical treatments gaining popularity, increasing product launch approval are driving the Acne Treatment Market. Furthermore, voluntary product recall by market players, stringent regulatory policies, and side effects and safety concerns across the globe is boosting the growth of the market.

Bausch Health Companies Inc. is a global, diversified specialty pharmaceutical and medical device company that develops, manufactures, and markets a wide range of products. These include branded, generic, and branded generic pharmaceuticals, over-the-counter (OTC) products, and aesthetic medical devices. The company operates in therapeutic areas such as gastroenterology, hepatology, neurology, and dermatology. Moreover, in October 2023, Bausch Health Companies Inc. and its dermatology division, Ortho Dermatologics, announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application for CABTREO (clindamycin phosphate, adapalene, and benzoyl peroxide) Topical Gel 1.2%/0.15%/3.1%. The gel is indicated for the topical treatment of acne vulgaris in patients aged twelve years and older.

Key Companies in the Acne Treatment Market include.

• Pfizer Inc. (US)




• Abbvie, Inc. (US)




• Bausch Health Companies Inc. (Canada)




• Galderma (Switzerland)




• Mayne Pharma (Australia)




• Cosette Pharmaceuticals (US)




• Johnson & Johnson Inc (US)




• Sun Pharmaceutical Industries, Ltd. (India)




• Hoffmann-La Roche Ltd. (Switzerland)




• GSK PLC (UK)

Pharmaceutical Excipients Industry Developments

August 2023: Bausch Health Companies Inc. and its dermatology division, Ortho Dermatologics, announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application for CABTREO (clindamycin phosphate, adapalene, and benzoyl peroxide) Topical Gel 1.2%/0.15%/3.1%. This approval marks CABTREO as the first and only FDA-approved fixed-dose, triple-combination topical treatment for acne vulgaris in patients aged twelve and older.

July 2023: Cosette Pharmaceuticals has introduced Dapsone 5% Gel, an AB-rated alternative to Aczone 5%, offering an important and cost-effective treatment option for patients with acne.

July 2022: Galderma announced the launch of EPSOLAY (benzoyl peroxide) cream, 5%, in the U.S. following its approval by the U.S. Food and Drug Administration (FDA) on April 22, 2022. EPSOLAY Cream is the first and only microencapsulated benzoyl peroxide (E-BPO) topical treatment specifically proven to relieve the bumps and blemishes associated with rosacea, offering rapid, significant, and sustained relief.

Acne Treatment Market Segmentation:

Acne Treatment Market Therapeutic Type Outlook

• Oral
  
  
  
  
  
  • Antibiotics
  
  
  
  
  • Contraceptives
  
  
  
  
  • Retinoids
  
  
  
  
  • Hormonal
  
  
  
  
  
  
  
  




• Topical
  
  
  
  
  
  • Antibiotics
  
  
  
  
  • Retinoids
  
  
  
  
  • Benzoyl Peroxide
  
  
  
  
  • Salicylic Acid
  
  
  
  
  • Azelaic Acid
  
  
  
  
  • Others
  
  
  
  
  
  
  
  




• Systemic
  
  
  
  
  
  • Antibiotics
  
  
  
  
  • Intralesional Steroid Injections
  
  
  
  
  
  
  
  




• Acne Treatment Market Prescription Type Outlook




• Prescription-based




• Over-the-counter (Non-prescription-based)




• Acne Treatment Market Acne Severity Outlook




• Low




• Moderate




• High




• Acne Treatment Market Gender Outlook




• Male




• Female




• Acne Treatment Market Distribution Channel Outlook




• Hospital Pharmacies




• Retail Pharmacies




• Online




• Acne Treatment Market Regional Outlook




• North America
  
  
  
  
  
  • US
  
  
  
  
  • Canada
  
  
  
  
  • Mexico
  
  
  
  
  
  
  
  




• Europe
  
  
  
  
  
  • Germany
  
  
  
  
  • France
  
  
  
  
  • UK
  
  
  
  
  • Italy
  
  
  
  
  • Spain
  
  
  
  
  • Itay
  
  
  
  
  • Russia
  
  
  
  
  • Rest of Europe
  
  
  
  
  
  
  
  




• Asia-Pacific
  
  
  
  
  
  • China
  
  
  
  
  • India
  
  
  
  
  • Japan
  
  
  
  
  • South Korea
  
  
  
  
  • Australia
  
  
  
  
  • Malaysia
  
  
  
  
  • Thailand
  
  
  
  
  • Indonesia
  
  
  
  
  • Rest of Asia-Pacific
  
  
  
  
  
  
  
  




• South America
  
  
  
  
  
  • Brazil
  
  
  
  
  • Mexico
  
  
  
  
  • Argentina
  
  
  
  
  • Rest of South America
  
  
  
  
  
  
  
  




• Middle East and Africa
  
  
  
  
  
  • Brazil
  
  
  
  
  • Mexico
  
  
  
  
  • Argentina
  
  
  
  
  • Rest of South America
  
  
  
  
  
  
  
  

Report Attribute/Metric	Details
Market Size 2024	USD 10.00 billion
Market Size 2025	USD 10.40 billion
Market Size 2035	USD 15.98 billion
Compound Annual Growth Rate (CAGR)	5.34% (2025-2035)
Base Year	2024
Forecast Period	2025-2035
Historical Data	2019 to 2023
Forecast Units	Value (USD Billion)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered	Therapeutic Type, Prescription Type, Acne Severity, Gender, Distribution Channel, and Region
Geographies Covered	North America, Europe, Asia Pacific, South America, and Middle East and Africa
Countries Covered	The US, Canada, Brazil, Germany, France, the UK, Italy, Spain, China, India, Japan, South Korea, Australia.
Key Companies Profiled	Pfizer Inc. (US), Abbvie, Inc. (US), Bausch Health Companies Inc. (Canada), Galderma (Switzerland), Mayne Pharma (Australia), Cosette Pharmaceuticals (US), Johnson & Johnson Inc (US), Sun Pharmaceutical Industries, Ltd. (India), F. Hoffmann-La Roche Ltd. (Switzerland), GSK PLC (UK), and others
Key Market Opportunities	·         Growth in e-commerce and online pharmacies ·         Increasing funding and investment by acne treatment products manufacturer ·         Increasing disposable income creates opportunities
Key Market Drivers	·         Growing prevalence of acne across the globe ·         Topical treatments gaining popularity  ·         Increasing product launch approval